Nykode Therapeutics ASA

Last updated September 27, 2026

Organization details

Legal name
Nykode Therapeutics ASA
Also known as (brands, DBAs, abbreviations)
Nykode Therapeutic
Ownership
Public
Status
Active
Headquarters city
Oslo
Headquarters country
Norway
Ticker symbol
NYKD
Primary stock exchange
Euronext

Identifiers

LEI
254900UKQHWYZJD22017
ISIN
NO0010714785
Norwegian organization number
990646066

Board of directors

Chief executives

Michael Thyrring Engsig · Chief executive (daglig leder)
Dates unknown

Board connections

1 of this board's directors also sit on 1 other board.

Network of Nykode Therapeutics ASA's board connections Gentian Diagnostics ASA Gentian Diagnostics AS... Christian Åbyholm Christian Åbyholm Nykode Therapeutics ASA
Shared director Other board Same sector

Questions about Nykode Therapeutics ASA

Who is the CEO of Nykode Therapeutics ASA?

Michael Thyrring Engsig is Nykode Therapeutics ASA's Chief executive (daglig leder).

Who is the chair of Nykode Therapeutics ASA's board?

Barbara Helene Hannelore Krebs-Pohl chairs Nykode Therapeutics ASA's board of directors.

How many directors are on Nykode Therapeutics ASA's board?

Nykode Therapeutics ASA's board has 5 directors: Barbara Helene Hannelore Krebs-Pohl, Christian Åbyholm, John William Beadle, Susanne Stuffers and Trygve Lauvdal.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="nykode-therapeutics-asa"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.